David Mitchell, PharmD, MBA, UC Davis, shares how collaboration between health systems and manufacturers is transforming patient access and outcomes for rare disease treatments.
Expanding community-based cancer services brings advanced treatments closer to home and addresses social determinants of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback